Clinical Trial Update: Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC [Phase 1]

View source ↗

Summary

Phase 1 randomized trial evaluating glutathione in combination with an anti-PD-1 antibody and chemotherapy for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Glutathione (glutathione)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Non-Small Cell Lung Cancer, Chemotherapy | Phase 1 | Status: RECRUITING